Gousse A E, Madjar S, Lambert M M, Fishman I J
Urology Department, University of Miami, Jackson's Memorial Hospital, Miami, Florida, USA.
J Urol. 2001 Nov;166(5):1755-8.
Incontinence affects between 3% and 60% of patients after radical prostatectomy. Insertion of an artificial urinary sphincter is a mainstay therapeutic option available to these patients. We assessed patient satisfaction, outcome and complications long after artificial urinary sphincter implantation.
From a data bank of 131 patients who underwent artificial urinary sphincter prosthesis insertion we identified 71 with a mean age of 72 years who had also undergone radical prostatectomy and were available for evaluation. This group included 29 patients (40.8%) who received an earlier version of the AMS-800 (American Medical Systems, Minnetonka, Minnesota) and 42 (59.2%) who received the newer narrow back cuff device. Information on surgical procedures and followup were obtained from a computerized database. Patients were also contacted by an impartial reviewer who administered a standard telephone questionnaire on the degree of continence, complications, other means used to help with urinary continence, proficiency in device operation and satisfaction.
At a mean followup of 7.7 years (range 0.5 to 16) 19 patients (27%) used 0, 23 (32%) used 1, 11 (15%) used 1 to 3 and 18 (25%) used more than 3 daily, while 1 used an external catheter. Surgical revision in 21 cases (29%) was required due to mechanical failure in 18 (25%), device erosion in 3 (4%) and infection in 1 (1.4%). The need for revision correlated significantly with the design of the sphincter (p = 0.005). Only 7 of the 42 patients in whom a narrow cuff AMS-800 was implanted needed revision versus 18 of the 23 with a previous design. Mean time to revision was 2.5 years (range 0.5 to 8). The device was removed in 2 cases (2.8%). Of the patients 41 (58%) are very satisfied, 14 (19%) are satisfied and 16 (23%) are unsatisfied with the device. The degree of satisfaction correlated with the number of pads used (p = 0.0005) and sphincter design (0.028) but not with the number of surgical revisions (p = 0.521) or patient age.
The artificial urinary sphincter is a viable treatment option for post-radical prostatectomy incontinence with a high rate of continence and satisfaction for a long period after the procedure. Patients should be informed that complications necessitating device revision and explantation may appear late in followup. A standard definition of treatment success and studies of homogenous groups of patients with an artificial urinary sphincter would enable better understanding and patient education in the future.
根治性前列腺切除术后,3%至60%的患者会出现尿失禁。植入人工尿道括约肌是这些患者的主要治疗选择。我们评估了人工尿道括约肌植入术后很长一段时间患者的满意度、治疗效果及并发症情况。
在131例行人工尿道括约肌假体植入的患者数据库中,我们确定了71例平均年龄72岁的患者,他们均接受了根治性前列腺切除术且可供评估。该组包括29例(40.8%)接受早期版本AMS - 800(美国医疗系统公司,明尼通卡,明尼苏达州)的患者和42例(59.2%)接受新型窄背袖带装置的患者。手术程序及随访信息来自计算机数据库。还由一名公正的评估人员联系患者,对其进行关于尿失禁程度、并发症、用于辅助尿失禁的其他方法、设备操作熟练程度及满意度的标准电话问卷调查。
平均随访7.7年(范围0.5至16年),19例(27%)患者每天使用0次,23例(32%)使用1次,11例(15%)使用1至3次,18例(25%)使用超过3次,1例使用外置导尿管。21例(29%)患者因机械故障18例(25%)、装置侵蚀3例(4%)和感染1例(1.4%)需要进行手术翻修。翻修需求与括约肌设计显著相关(p = 0.005)。植入窄袖带AMS - 800的42例患者中仅7例需要翻修,而采用先前设计的23例中有18例需要翻修。平均翻修时间为2.5年(范围0.5至8年)。2例(2.8%)患者移除了该装置。41例(58%)患者对该装置非常满意,14例(19%)满意,16例(